Landos Biopharma, Inc. - Common Stock (NQ:LABP)
Price and Volume
Detailed QuoteVolume | 0 |
Open | - |
Bid (Size) | 22.47 (8) |
Ask (Size) | 24.51 (1) |
Prev. Close | 22.93 |
Today's Range | N/A - N/A |
52wk Range | N/A - N/A |
Shares Outstanding | 31,168,449 |
Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More

From Brodsky & Smith LLC
Via GlobeNewswire

Recap: Landos Biopharma Q4 Earnings
March 21, 2024
Via Benzinga


Nasdaq Turns Higher; Akanda Shares Plunge
March 25, 2024

12 Health Care Stocks Moving In Monday's Intraday Session
March 25, 2024
Via Benzinga

Is the Stock Market Closed on Good Friday 2024?
March 25, 2024
Via InvestorPlace

Landos Biopharma: Q3 Earnings Insights
November 09, 2023
Via Benzinga

Recap: Landos Biopharma Q1 Earnings
May 12, 2023
Via Benzinga


Why Is Landos Biopharma (LABP) Stock Up 168% Today?
March 25, 2024
Via InvestorPlace

Crude Oil Moves Higher; US New Home Sales Fall In February
March 25, 2024





12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via Benzinga

LABP Stock Earnings: Landos Biopharma Misses EPS for Q4 2023
March 21, 2024
Via InvestorPlace

Landos Biopharma - Investor Like It Better Than Analysts
March 07, 2024
Via Talk Markets

Via Benzinga

Via Benzinga

Via Benzinga
Frequently Asked Questions
Is Landos Biopharma, Inc. - Common Stock publicly traded?
Yes, Landos Biopharma, Inc. - Common Stock is publicly traded.
What exchange does Landos Biopharma, Inc. - Common Stock trade on?
Landos Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Landos Biopharma, Inc. - Common Stock?
The ticker symbol for Landos Biopharma, Inc. - Common Stock is LABP on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.